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Abstract
Background: The ability of medical residents training at U.S. urban medical centers to diagnose
and manage tuberculosis cases has important public health implications. We assessed medical
resident knowledge about tuberculosis diagnosis and early management based on American
Thoracic Society guidelines.
Methods:  A 20-question tuberculosis knowledge survey was administered to 131 medical
residents during a single routinely scheduled teaching conference at four different urban medical
centers in Baltimore and Philadelphia. Survey questions were divided into 5 different subject
categories. Data was collected pertaining to institution, year of residency training, and self-reported
number of patients managed for tuberculosis within the previous year. The Kruskal-Wallis test was
used to detect differences in median percent of questions answered correctly based on these
variables.
Results: The median percent of survey questions answered correctly for all participating residents
was 55%. Medical resident knowledge about tuberculosis did not improve with increasing post-
graduate year of training or greater number of patients managed for tuberculosis within the
previous year. Common areas of knowledge deficiency included the diagnosis and management of
latent tuberculosis infection (median percent correct, 40.7%), as well as the interpretation of
negative acid-fast sputum smear samples.
Conclusion: Many medical residents lack adequate knowledge of recommended guidelines for the
management of tuberculosis. Since experience during training influences future practice pattterns,
education of medical residents on guidelines for detection and early management of tuberculosis
may be important for future improvements in national tuberculosis control strategies.
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Background
Although the overwhelming global burden of Mycobacte-
rium tuberculosis disease occurs in developing countries,
developed countries have not been able to eradicate this
infection. After an increase in tuberculosis cases from
1985–1992, implementation of effective interventions at
the national, state, and local levels led to a decline in the
incidence of tuberculosis in the U.S. by 44% from 1993 to
2003 [1], to a historic low level (14,874 cases, represent-
ing 5.1 cases/100,000 population in 2003) [2]. However,
as a result of continued immigration from countries with
a high prevalence of tuberculosis [3], it is possible that
recent encouraging trends in tuberculosis incidence in the
U.S. may be reversed in the near future. In addition, the
estimated 10 to 15 million persons in the United States
with latent tuberculosis infection [1] represent a signifi-
cant reservoir for subsequent tuberculosis reactivation.
Social factors, including homelessness, injection drug use,
incarceration, and immigration, as well as concurrent HIV
infection, have contributed to the high prevalence of
tuberculosis in urban areas in the US [4]. Many of these
patients will be seen and evaluated first by internists and
primary care physicians. Because care patterns learned in
training are reflected in later practice [5], it is important to
ensure that future internists have an appropriate aware-
ness of this important infection. From a public health per-
spective, medical resident physicians training at urban
medical centers are likely to be present when patients with
previously undiagnosed tuberculosis first encounter the
medical health system.
We evaluated medical resident knowledge of tuberculosis
diagnosis and early management based on American Tho-
racic Society guidelines [6-10] at four urban internal med-
icine residency training programs in Baltimore and
Philadelphia. We assessed knowledge based on a brief
written examination and then evaluated scores on the
examination with respect to institution, post-graduate
year of training, and number of tuberculosis cases seen
within the past year. As a result, we identified specific
areas of knowledge deficiency that we believe require fur-
ther attention in medical residency curricula.
Methods
A survey (see Appendix 1) comprising 20 questions (11
multiple-choice and 9 true/false) was developed by the
collaborating authors and reviewed for face and content
validity. The survey was pilot tested among 17 infectious
disease attending physicians from the participating insti-
tutions, 8 of whom described themselves as tuberculosis
experts. The median percent of survey questions answered
correctly in this group was 90%, and based on their
responses, a single question (Question # 2) was deemed
ambiguous by the participating authors, and this question
was omitted from the data analysis. The knowledge sur-
veys were administered anonymously to internal medi-
cine residents at the following four accredited U.S.
residency training programs: Johns Hopkins Hospital,
Baltimore, MD; Johns Hopkins Bayview Medical Center,
Baltimore, MD; University of Maryland Medical Center,
Baltimore, MD; and Hospital of the University of Pennsyl-
vania, Philadelphia, PA. The collaborating authors
administered surveys during a single routinely scheduled
teaching conference at each of their respective institutions
in the final month of the academic year in 2005. To pre-
vent residents from studying the subject in anticipation,
the surveys were distributed without advance notice. Med-
ical residents were allowed up to 30 minutes to complete
the surveys without outside assistance. Correct responses
were determined prior to survey administration according
to published American Thoracic Society guidelines (see
Appendix 2) [6-10]. Each completed survey was assigned
a score based on the percent of questions answered cor-
rectly, with a maximum survey score of 100% represent-
ing correct responses to all 19 questions.
Data were collected pertaining to institution, year of resi-
dency training, and self-reported number of patients man-
aged for tuberculosis within the previous year. For
purposes of data analysis, each institution randomly was
assigned a number from 1 to 4. We used the Kruskal-Wal-
lis test to detect differences in median survey scores based
on these variables. Survey questions were divided into 5
categories: transmission of M. tuberculosis (questions #3,
12, and 13); diagnosis and management of latent tubercu-
losis infection (questions #1, 4, 5, 6, 7, 10, and 11); diag-
nosis of active tuberculosis (questions #14, 15, 16, 17,
and 18); toxicity of anti-tuberculosis therapy (questions
#8, 9, and 19); and HIV and tuberculosis co-infection
(questions #7, 19, and 20).
This study was approved by the Institutional Review
Board of each participating institution, and the need for
written informed consent was waived.
Results
General characteristics of survey respondents
The surveys were completed by 131 medical residents,
representing 29% of the 446 total medical residents train-
ing at the four participating institutions. Survey response
rates among conference attendees at each institution were
100%. Forty-one percent (n = 53) of participating resi-
dents were from institution 1, 21% (n = 28) were from
institution 2, 16% (n = 21) were from institution 3, and
22% (n = 29) were from institution 4. Respondents were
evenly distributed with respect to their level of residency
training; 35% (n = 46) were post-graduate year (PGY)-1,
32% (n = 41) were PGY-2, and 33% (n = 43) were PGY-3.
Nearly half of all respondents (48%, n = 60) had directlyBMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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cared for only 1 or 2 patients with tuberculosis in the pre-
vious year, and 29% (n = 36) of respondents had cared for
3 or more patients with tuberculosis. Twenty-three per-
cent (n = 29) had not cared for a single patient with tuber-
culosis in the previous year (Table 1).
The median survey score for all participating medical res-
idents was 55%. Overall, survey performance did not cor-
relate with level of residency training, as median scores for
PGY-1, PGY-2, and PGY-3 residents were 55% for all years
(p = 0.94). Interestingly, median scores among residents
who had directly cared for 3 or more patients with tuber-
culosis within the previous year (52%) were significantly
lower than those among residents who had cared 1–2
patients (60%; p = 0.04). Finally, survey scores were some-
what influenced by institution, as median scores for insti-
tutions 1, 2, 3, and 4 were 55%, 55%, 50%, and 65%,
respectively (p = 0.03) (Table 1).
Transmission of Mycobacterium tuberculosis
The median score for all medical residents in the category
of M. tuberculosis transmission was 95% (Table 2). Half of
all medical residents (n = 66) responded correctly to all 3
relevant questions. Eighty-one percent (n = 106) recog-
nized correctly that no specific effective measures exist to
prevent acquisition of M. tuberculosis in areas of high prev-
alence of the disease, and only 5% (n = 7) incorrectly rec-
ommended vaccination with BCG for a traveler to a
tuberculosis endemic area (Question #3). Eighty-seven
percent of residents (n = 112) correctly identified patients
with extrapulmonary tuberculosis as being less likely to
transmit  M. tuberculosis than those with pulmonary
involvement (Question #13). Seventy-two percent of resi-
dents (n = 36) correctly recognized that patients whose
sputum samples are negative by acid fast staining may still
transmit M. tuberculosis (Question #12).
Diagnosis and management of latent tuberculosis infection
The median score for all medical residents in the category
of latent tuberculosis infection was 40.7%. Although
medical residents from institution 4 received the highest
median scores in this category (median, 54.2%, p < 0.01),
their scores represent only one more correct answer above
median scores from all institutions combined. Interpreta-
tion of tuberculin skin test results posed particular diffi-
culty for the participating medical residents. When
presented with a clinical vignette describing a foreign-
born, BCG-vaccinated individual, whose tuberculin skin
test is positive (Question #1), fewer than half of residents
would treat with the appropriate regimen of isoniazid for
9 months (47%; n = 62). Among those responding incor-
rectly to this question, 71% believed that the positive
tuberculin skin test was attributable to prior BCG vaccina-
tion, and recommended no specific therapy for latent
tuberculosis infection. Sixty-six percent of residents (n =
85) correctly recognized that a tuberculin skin test induc-
ing a 5-mm reaction is not considered positive for health
care workers (Question #5).
With respect to the therapy of latent tuberculosis infec-
tion, only 41% of residents (n = 53) identified the combi-
nation of rifampin and pyrazinamide as an unacceptable
regimen, and half of residents (n = 67) were aware of the
acceptability of a 4-month regimen of rifampin for the
Table 1: Medical Resident Background and Median Survey Scores (Percent Correct)
N (%) Median score
Overall 131 (100) 55.0
Institution
1 53 (40.5) 55.0
2 28 (21.4) 55.0
3 21 (16.0) 50.0
4 29 (22.1) 65.0
p-value 0.03
TB patients seen within last year
0 29 (23.2) 55.0
1–2 60 (48.0) 60.0
3 or more 36 (28.8) 52.5
p-value 0.04
Years of training
1 46 (35.4) 55.0
2 41 (31.5) 55.0
3 43 (33.1) 55.0
p-value 0.80BMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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treatment of latent tuberculosis infection (Question #4).
Only 15% (n = 108) were aware of the proper use of pyri-
doxine supplementation (Question #10), with three-
quarters of incorrect responders choosing not to recom-
mend pyridoxine supplementation during pregnancy.
Nearly half of residents (n = 64) believed incorrectly that
the lifetime risk of developing active disease in non-HIV-
infected persons with latent tuberculosis infection was
below 2 percent (Question #6). Fifty-five percent of resi-
dents (n = 71) correctly identified the use of infliximab as
the greatest risk factor for progression from latent tubercu-
losis infection to active disease among other possible risk
factors including age, rheumatoid arthritis, methotrexate
use, and smoking history (Question #11).
Diagnosis of active tuberculosis
The median score for all medical residents in the category
of active tuberculosis diagnosis was 57%. The great major-
ity of residents (97 percent, n = 125) correctly indicated
that the diagnosis of pulmonary tuberculosis cannot be
reliably excluded on the basis of a negative tuberculin skin
test (Question #14). However, only 28% of residents (n =
93) recognized that the diagnosis of pulmonary tubercu-
losis cannot be reliably excluded after 3 sequential spu-
tum samples are negative by acid fast staining (Question
#15). Similarly, only 40% of residents (n = 78) recognized
that the diagnosis of pulmonary tuberculosis cannot be
reliably excluded after a single bronchoscopic alveolar lav-
age sample is negative by acid fast staining (Question
#16). Regarding the use of nucleic acid amplification test-
ing of sputum samples in the diagnosis of pulmonary
tuberculosis, roughly three-quarters of residents (n = 101)
recognized the high specificity of the test for acid fast-pos-
itive sputum samples (Question #17), and two-thirds (n =
89) recognized the reduced sensitivity of the test for acid-
fast sputum negative samples (Question #18).
Toxicity of therapy for active tuberculosis
The median score for all medical residents in the category
of anti-tuberculosis therapy-associated toxicity was
63.3%. With respect to initial four-drug combination
therapy for active tuberculosis cases, 80% of residents
were aware of rifampin-related staining of secretions, and
90% were aware of the potential hepatotoxicity of the reg-
imen (Question #8). When confronted with a patient
experiencing a 2-fold elevation in aspartate aminotrans-
ferase (AST) above baseline values after initiation of ther-
apy for active tuberculosis, 30% of residents (n = 39)
incorrectly recommended discontinuation of one or more
anti-tuberculous drugs (Question #9).
Human immunodeficiency virus and tuberculosis co-
infection
The median score for all medical residents in the category
of HIV and tuberculosis co-infection was 63.3%. Many
residents (39%, n = 51) incorrectly thought that the
annual risk of developing active disease in HIV-infected
patients with latent tuberculosis infection was less than or
equal to 1 percent (Question #7).
The majority of residents (84%, n = 102) correctly identi-
fied rifampin as the first-line anti-tuberculous agent with
the greatest potential for drug-drug interactions in
patients receiving highly active antiretroviral therapy
(HAART) (Question #19). Nearly 80% of residents (n =
105) correctly would not delay initiation of HAART until
active tuberculosis had been completely treated in HIV-
infected patients with CD4 cell counts below 100 cells/
mm3 (Question #20).
Discussion
One major challenge facing current tuberculosis eradica-
tion efforts in the U.S. is the maintenance of clinical and
public health expertise in an era of declining disease inci-
dence. Lack of such expertise may lead to delayed detec-
tion of active tuberculosis cases, resulting in delayed
initiation of treatment and the potential for continued
transmission of the organism [11-15]. From a public
health point of view, it is imperative that medical house-
staff training at urban medical centers be able to recognize
and promptly treat this infection, since these centers treat
the majority of tuberculosis cases in the U.S. [16,17]. It is
also important to ensure that future internists are compe-
tent in the diagnosis and early management of latent and
active tuberculosis infections.
Consistent with previous reports indicating defiencies in
U.S. physician trainee knowledge of national disease-spe-
cific guidelines [18-20], our study revealed that many
Table 2: Median percent of questions answered correctly by all residents in each subject category
Subject category Percent correct (median)
Transmission of M. tuberculosis 95.0
Diagnosis and management of latent tuberculosis infection 40.7
Diagnosis of active tuberculosis 57.0
Toxicity of therapy for active tuberculosis 63.3
Human immunodeficiency virus and tuberculosis co-infection 63.3BMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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medical residents lack adequate knowledge of recom-
mended guidelines for the management of tuberculosis.
Contrary to our initial hypotheses, medical resident
knowledge about tuberculosis did not improve with
increasing PGY level of training or volume of tuberculosis
patients. Interestingly, the lowest median scores were
observed in the group of residents who had directly cared
for the greatest number of patients with tuberculosis
within the previous year. This finding, although statisti-
cally significant, may not be clinically relevant, since
median scores between the groups differed at most by a
single question. Alternatively, medical residents who had
directly cared for a large number of patients with tubercu-
losis within the previous year may have done so during
rotations in developing countries, where tuberculosis edu-
cation may not comply with current U.S. guidelines. In
support of this hypothesis, a recent study demonstrated
poor awareness of and low compliance with published
tuberculosis guidelines among medical interns in Paki-
stan, a country with a high prevalence of tuberculosis [21].
Although resident median scores were somewhat influ-
enced by institution, the median score at the institution
with the highest scores exceeded the overall median by
only a single correct answer.
In order to gain insight into specific areas of resident
knowledge deficiency, we divided the questions into 5
specific categories (see Methods). Among these categories,
the median score was highest for questions pertaining to
transmission of M. tuberculosis (95.0%), with nearly half
of all residents responding correctly to all questions
within this category. The category for which the medical
residents received the lowest median score was that of
diagnosis and management of latent tuberculosis infec-
tion (median score, 40.7%). This result is perhaps not sur-
prising, since internal medicine residency training in the
U.S. occurs mostly in the inpatient setting [22], while
latent tuberculosis infection is often diagnosed and man-
aged in the outpatient setting.
Analysis of individual questions pertaining to latent
tuberculosis infection revealed several common miscon-
ceptions among medical residents. One common error
was the false attribution of a positive tuberculin skin test
to distant BCG vaccination in a person from a tuberculo-
sis-endemic country. Although prior receipt of BCG vac-
cine in some cases may lead to a positive tuberculin skin
test, this effect wanes significantly over time [23-25].
Therefore, current guidelines recommend treatment for
latent tuberculosis infection in persons with positive skin
tests who are from tuberculosis-endemic areas, regardless
of prior BCG vaccination history [8]. Recently developed
interferon gamma release assays using Mycobacterium
tuberculosis-specific antigens have shown promise in diag-
nosing latent tuberculosis infection in high-risk individu-
als [26,27], and appear to have the advantage of decreased
cross-reactivity in individuals exposed to BCG and nontu-
berculous mycobacteria [28]. A large proportion of the
residents was not familiar with appropriate and inappro-
priate treatment regimens for latent tuberculosis infec-
tion, with less than half of residents identifying 2 months
of rifampin and pyrazinamide as unacceptable, despite
the proscription of this regimen in current guidelines due
to its significantly increased risk of severe hepatotoxicity
[10]. A significant proportion of residents grossly under-
estimated the risk of progression from latent tuberculosis
infection to active disease in HIV-infected and HIV-unin-
fected individuals, and did not recognize the importance
of infliximab use as a major risk factor in predicting reac-
tivation of tuberculosis [29]. These findings underscore
the need to instruct medical residents about the impor-
tance of promptly diagnosing and treating latent tubercu-
losis infection in high-risk populations.
Another common misconception among medical resi-
dents was that acid fast smear negativity reliably excludes
the diagnosis of pulmonary tuberculosis and precludes
transmissibility of infection. This misconception may be
based on hospital infection control practice guidelines,
which often recommend discontinuation of respiratory
isolation for tuberculosis suspect patients after demon-
stration of sputum smear-negativity [30]. However, an
epidemiologic study of tuberculosis cases in San Francisco
used DNA fingerprinting to demonstrate that although
acid fast-negative culture-positive patients were less infec-
tious than acid fast-positive cases, the former group were
still responsible for about 17% of M. tuberculosis transmis-
sion [31].
Our study has several limitations. The survey was con-
ducted at medical residency training programs in Balti-
more, MD, and Philadelphia, PA, cities with a moderate
prevalence of tuberculosis; the case rates per 100,000 pop-
ulation were 4.5 and 4.2 for Baltimore and Philadelphia,
respectively, in 2004 [32]. Therefore, it is possible that our
results may underestimate medical resident knowledge in
cities with higher case rates of tuberculosis, such as New
York City (11.9/100,000 population), Houston (11.2/
100,000 population), or Los Angeles (10.0/100,000 pop-
ulation), or overestimate medical resident knowledge in
cities or rural areas with a lower prevalence of tuberculo-
sis. However, our data and those of others [21] suggest
that medical resident knowledge does not improve with
the number of tuberculosis cases seen. Surveys were com-
pleted by only 29% of medical residents at the participat-
ing institutions, primarily because of the study design.
Our survey was administered during a single scheduled
resident conference at each of the four participating insti-
tutions in order to maximize the number of survey
respondents while minimizing the potential for use ofBMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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outside sources of information. Therefore, the poor survey
response rates in fact reflect poor resident conference
attendance. On the other hand, survey response rates
among conference attendees at each institution were
100%. It is possible that sole inclusion of conference
attendees may have introduced inadvertent bias into the
subject pool. However, attendance at didactic teaching
conferences does not appear to correlate with medical res-
ident knowledge, at least as measured by performance in
medical certifying examinations [33]. Finally, we cannot
be sure that lack of tuberculosis knowledge leads to poor
management of patients. Although trainees may score
poorly, they may be quick to consult experts in Infection
Control, Infectious Diseases, or Pulmonary Medicine to
assist in diagnosis, isolation, and treatment. Resources
pertaining to the education of undergraduate and gradu-
ate health-related students in the management and con-
trol of active and latent tuberculosis infection may be
found at the website of the National Tuberculosis Curric-
ulum Consortium.
Conclusion
The ability of medical residents training at U.S. urban
medical centers to diagnose and manage tuberculosis
infection has important public health implications. Over-
all, medical residents appear to have significant knowl-
edge gaps in several aspects of tuberculosis care, including
the diagnosis and treatment of latent tuberculosis infec-
tion, and the correct interpretation of negative acid-fast
smear sputum samples. Since clinical practice paradigms
are often ingrained in physicians during their residency
training, education of medical residents on guidelines for
detection and early management of tuberculosis may be
important for future improvements in national tuberculo-
sis control strategies.
Appendix 1: Medical resident TB knowledge 
survey
Assessment of tuberculosis knowledge among primary care 
residents in urban medical centers
Given the increasing prevalence of tuberculosis (TB) cases
in urban areas related to homelessness, incarceration,
immigration, and concurrent human immunodeficiency
virus (HIV) infection, it is imperative that primary care
physicians in urban medical centers are able to recognize
and treat this important infection. The purpose of the pro-
posed research is to assess the adequacy of U.S. graduate
medical training regarding TB in large urban medical cent-
ers, which has not been studied previously.
We are conducting a survey of 1st, 2nd, and 3rd year resident
physicians enrolled in Internal Medicine training pro-
grams at Johns Hopkins Hospital, Johns Hopkins Bayview
Medical Center, University of Maryland, and University of
Pennsylvania. Surveys consist of 20 multiple-choice and
true/false questions related to the epidemiology, diagno-
sis, and management of patients with TB.
Your participation in this study is entirely VOLUNTARY.
Therefore, you may choose not to participate at any time.
If you choose to participate, you will have 30 minutes to
complete the survey, which must be done without the aid
of textbooks or other auxiliary materials. Surveys will bear
NO IDENTIFYING INFORMATION, other than year of
residency training. Upon completion of the study, you
will be provided with the study results, including correct
responses to each question and pertinent explanations.
Assessment of tuberculosis knowledge among primary care 
residents in urban medical centers
Please answer the following background questions (check only one)
Post-graduate year (PGY) of training (Intern = PGY 1,
etc.):
 PGY 1  PGY 2  PGY 3  Other
Number of patients with tuberculosis for whom you have
directly cared in the last year:
 None  1–2  3–5  5–10  More than 10
For each of the following case scenarios, please circle the most 
appropriate answer (circle only one)
1. A 32 year-old asymptomatic woman who recently emi-
grated from Vietnam has a 12 mm indurated reaction 72
hours after a tuberculin skin test was placed for employ-
ment purposes. Her chest X-ray is unremarkable. She has
normal liver function tests. She states she received the
BCG vaccine at birth and again at age 20. The next course
of action is:
a. Four-drug therapy with isoniazid, rifampin, ethambu-
tol, and pyrazinamide for 2 months, followed by 4
months of isoniazid and rifampin
b. Isoniazid with vitamin B6 for 9 months
c. Sputum sample for acid-fast bacilli and cultures
d. No treatment; the positive tuberculin skin test may be
explained by the history of BCG vaccination
2. A 29 year-old homeless man presents to your clinic with
a 2-month history of fevers, night sweats, and weight loss.
He denies cough or hemoptysis. On physical examination
you detect cervical lymphadenopathy, and a chest X-ray
reveals normal lung fields but enlarged mediastinal
lymph nodes. You suspect extrapulmonary tuberculosis.
You place a tuberculin skin test. The next course of action
is:BMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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a. Sputum sample for acid-fast bacilli and cultures
b. Cervical lymph node biopsy for acid-fast staining and
mycobacterial cultures
c. Blood cultures for mycobacteria
d. Serum early secreted antigen-6 (ESAT-6)
3. One of your co-workers is being relocated to Mali for 2
years. He inquires about tuberculosis prophylaxis. You
recommend:
a. BCG vaccination
b. Daily isoniazid during his stay
c. Weekly rifampin during his stay
d. The use of N-95 respiratory masks while in crowded
public places
e. No specific prophylaxis
4. A 26 year-old asymptomatic man who recently immi-
grated from El Salvador is found to have a positive tuber-
culin skin test. The following are acceptable treatments for
latent tuberculosis infection EXCEPT:
a. Daily isoniazid for nine months
b. Daily rifampin for 4 months
c. Daily rifampin and pyrazinamide for 2 months
5. A 5-mm reaction after tuberculin skin test placement is
considered positive for all of the following cases EXCEPT:
a. 38 year-old woman with HIV
b. 24 year-old husband of a known TB case
c. 67 year-old man with fibrotic changes in the right upper
lobe on chest X-ray
d. 52 year-old woman on immunosuppression for renal
transplant
e. 32 year-old nurse working at university student health
clinic
6. The lifetime risk of developing active disease in non-
HIV-infected patients with latent tuberculosis infection is:
a. 0.1–0.5%
b. 1–2%
c. 5–10%
d. 25–35%
e. 50–75%
7. The annual risk of developing active disease in patients
with HIV and latent tuberculosis infection is approxi-
mately:
a. 0.1%
b. 1%
c. 10%
d. 25%
e. 50%
8. You have diagnosed a 30 year-old man with pulmonary
tuberculosis and have started therapy with a four-drug
combination including isoniazid, rifampin, pyrazina-
mide, and ethambutol. You should advise your patient of
the following EXCEPT:
a. To avoid the use of contact lenses
b. To limit the consumption of green leafy vegetables
c. To avoid alcohol consumption
d. To report changes in color vision
e. To report numbness or tingling of the extremities
9. A patient with no prior medical history is diagnosed
with pulmonary tuberculosis and you prescribe a daily
combination regimen containing isoniazid, rifampin,
pyrazinamide, and ethambutol. The patient sees his pri-
mary care doctor 3 weeks later for a scheduled office visit,
at which time routine chemistry tests reveal a 2-fold eleva-
tion of the aspartate aminotransferase (AST) above a nor-
mal baseline value. At this point, the patient should:
a. Discontinue isoniazid only
b. Discontinue rifampin only
c. Discontinue rifampin and pyrazinamide
d. Discontinue all anti-TB drugs until AST returns to base-
lineBMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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e. Continue current regimen and monitor symptoms and
transaminases
10. Pyridoxine supplementation (25 mg/day) during
treatment of latent tuberculosis infection is recommended
for the following patients EXCEPT:
a. 31 year-old pregnant woman
b. 28 year-old man with HIV
c. 74 year-old man with peripheral neuropathy
d. 21 year-old woman with anemia
11. A 67 year-old woman with rheumatoid arthritis and
chronic obstructive pulmonary disease presents with a
right upper lobe cavitary lesion. Her greatest risk factor for
tuberculosis is:
a. Age
b. History of rheumatoid arthritis
c. Prior use of methotrexate
d. Smoking history
e. Prior use of infliximab
The following are TRUE or FALSE statements. Please check the most 
appropriate answer (check only one)
12. Patients who are AFB smear-negative cannot transmit
Mycobacterium tuberculosis.
 True  False
13. Patients with extrapulmonary disease are less likely to
transmit Mycobacterium tuberculosis than those with pul-
monary involvement.
 True  False
14. The diagnosis of pulmonary tuberculosis can be relia-
bly excluded on the basis of a negative tuberculin skin test.
 True  False
15. The diagnosis of pulmonary tuberculosis can be relia-
bly excluded after 3 sequential sputum samples are nega-
tive for acid-fast bacilli (AFB).
 True  False
16. The diagnosis of pulmonary tuberculosis can be relia-
bly excluded after a single bronchoscopic alveolar lavage
sample is negative for acid-fast bacilli (AFB).
 True  False
17. A positive sputum sample using a nucleic acid ampli-
fication technique (e.g., the MTB direct test) indicates the
diagnosis of tuberculosis.
 True  False
18. A negative nucleic acid amplification test (e.g., the
MTB direct test) performed on an AFB-negative sputum
sample can reliably exclude the diagnosis of tuberculosis.
 True  False
19. Of first-line anti-TB agents, rifampin has the greatest
potential for drug-drug interactions in patients receiving
highly active antiretroviral therapy (HAART).
 True  False
20. In HIV-infected patients with CD4 < 100, HAART
should be withheld until active tuberculosis has been
completely treated.
 True  False
Appendix 2: Survey answer key (percent of all 
residents responding correctly)
1. B (47%)
2. B (56%)
3. E (81%)
4. C (41%)
5. E (66%)
6. C (45%)
7. C (47%)
8. B (62%)
9. E (70%)
10. D (15%)
11. E (55%)
12. F (72%)BMC Infectious Diseases 2007, 7:89 http://www.biomedcentral.com/1471-2334/7/89
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13. T (87%)
14. F (97%)
15. F (28%)
16. F (40%)
17. T (76%)
18. F (66%)
19. T (84%)
20. F (79%)
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